These include ACVR2 (activin receptor type 2), TAF1B (TATA box binding protein-associated factor) and HT001, also known as ASTE1 (asteroid homolog 1), which show mutation rates of more than 80% in MSI-H colorectal cancer [15–18]. This evidence concerns the gene ASTE1 and colorectal cancer.